Clinical Trial Update: Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating clofarabine/cytarabine with reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clofarabine (Clolar) (clofarabine)
• Cytarabine (Ara-C) (cytarabine)

Snippet

Sponsor: Nantes University Hospital | Conditions: AML | Phase 2 | Status: COMPLETED